GM1-gangliosidosis results from mutations in the β-galactosidase 1 (GLB1) gene, which, in turn, cause enzyme deficiency and accumulation of GM1-ganglioside in various tissues of patients, predominantly affecting the nervous system [7]. The gene discussed is GLB1; the disease is GM1 gangliosidosis.